Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 62017TO0666

Order of the General Court (Eighth Chamber) of 17 April 2018.
NeoCell Holding Company LLC v European Union Intellectual Property Office.
EU trade mark — Legal person governed by private law — No evidence of legal existence — Article 177(4) of the Rules of Procedure — Manifest inadmissibility.
Case T-666/17.

Court reports – general – 'Information on unpublished decisions' section

Order of the General Court (Eighth Chamber) of 17 April 2018 –
NeoCell v EUIPO (BIOACTIVE NEOCELL COLLAGEN)

(Case T‑666/17)

(EU trade mark — Legal person governed by private law — No evidence of legal existence — Article 177(4) of the Rules of Procedure — Manifest inadmissibility)

1. 

Actions for annulment—Locus standi—Legal persons—Meaning—Possession of legal personality in accordance with national law

(Art. 263, fourth para., TFEU; Rules of Procedure of the General Court, Art. 177(4))

(see para. 15)

2. 

Judicial proceedings—Admissibility of actions—Judged by reference to the situation when the application was lodged

(see para. 15)

3. 

Actions for annulment—Natural or legal persons—Locus standi—Action brought by a company no longer having legal personality at the time the action was brought following a merger agreement—No evidence of legal existence—Manifest inadmissibility

(Art. 263, fourth para., TFEU; Rules of Procedure of the General Court, Art. 177(4))

(see paras 16, 18-20, 22-27)

Re:

Action brought against the decision of the Second Board of Appeal of EUIPO of 18 July 2017 (Case R 147/2017-2), relating to the international registration designating the European Union in respect of the word mark BIOACTIVE NEOCELL COLLAGEN.

Operative part

1. 

The action is dismissed.

2. 

NeoCell Corporation shall pay the costs.
Top